BDF 8784

Drug Profile

BDF 8784

Latest Information Update: 19 Jun 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Beiersdorf
  • Class Cardiotonics
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure

Most Recent Events

  • 19 Jun 2001 Discontinued-Unspecified phase in Heart failure in Germany (Unknown route)
  • 10 Sep 1997 No-Development-Reported for Heart failure in Germany (Unknown route)
  • 20 Nov 1995 No-Development-Reported for Cardiovascular disorders in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top